{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:18:17Z","timestamp":1765232297229,"version":"3.46.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["25227"],"award-info":[{"award-number":["25227"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118052","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T10:55:05Z","timestamp":1593860105000},"page":"118052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity"],"prefix":"10.1016","volume":"257","author":[{"given":"Hamid","family":"Bakherad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Setayesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Ebrahim-Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118052_bb0005","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.12659\/MSM.904988","article-title":"Granulocyte-colony stimulating factor (G-CSF) accelerates wound healing in hemorrhagic shock rats by enhancing angiogenesis and attenuating apoptosis","volume":"23","author":"Huang","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.lfs.2020.118052_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.0904515","article-title":"Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation","volume":"78","author":"Iida","year":"2005","journal-title":"J. Leukoc. Biol."},{"year":"1994","series-title":"Mice Lacking Granulocyte Colony-stimulating Factor Have Chronic Neutropenia, Granulocyte and Macrophage Progenitor Cell Deficiency, and Impaired Neutrophil Mobilization","author":"Lieschke","key":"10.1016\/j.lfs.2020.118052_bb0015"},{"issue":"1","key":"10.1016\/j.lfs.2020.118052_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0268-960X(92)90007-D","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation","volume":"6","author":"Rapoport","year":"1992","journal-title":"Blood Rev."},{"year":"1990","series-title":"Human Granulocyte Colony-stimulating Factor: Biologic Activities and Receptor Characterization on Hematopoietic Cells and Small Cell Lung Cancer Cell Lines","author":"Avalos","key":"10.1016\/j.lfs.2020.118052_bb0025"},{"issue":"1","key":"10.1016\/j.lfs.2020.118052_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00146081","article-title":"Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth","volume":"27","author":"Kikuchi","year":"1996","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2020.118052_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1525-1438.2000.99076.x","article-title":"G-CSF receptor expression in ovarian cancer","volume":"10","author":"Ninci","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.lfs.2020.118052_bb0040","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/bjc.1997.254","article-title":"Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder","volume":"75","author":"Tachibana","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2020.118052_bb0045","first-page":"794","article-title":"Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma","volume":"58","author":"Tsuzuki","year":"1998","journal-title":"Cancer Res."},{"year":"1989","series-title":"Expression of Colony-stimulating Factor Genes by Normal Human Mesothelial Cells and Human Malignant Mesothelioma Cells Lines In Vitro","author":"Demetri","key":"10.1016\/j.lfs.2020.118052_bb0050"},{"year":"1985","series-title":"Constitutive Production of Leukemia Differentiation, Colony-stimulating, Erythroid Burst-promoting, and Pluripoietic Factors by a Human Hepatoma Cell Line: Characterization of the Leukemia Differentiation Factor","author":"Gabrilove","key":"10.1016\/j.lfs.2020.118052_bb0055"},{"issue":"9","key":"10.1016\/j.lfs.2020.118052_bb0060","first-page":"966","article-title":"Production of granulocyte colony-stimulating factor by a human melanoma cell line","volume":"15","author":"Lilly","year":"1987","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118052_bb0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcp.1041330228","article-title":"Intraclonal diversity of fibrosarcoma cells for the production of macrophage colony-stimulating factor and granulocyte colony-stimulating factor","volume":"133","author":"Sakai","year":"1987","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118052_bb0070","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0022-5347(17)35345-4","article-title":"Granulocyte colony-stimulating factor produced by bladder carcinoma of a patient with leukemoid reaction did not affect proliferation of the tumor cells","volume":"151","author":"Sato","year":"1994","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118052_bb0075","first-page":"209","article-title":"Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21","volume":"1","author":"Tweardy","year":"1987","journal-title":"Oncogene Res."},{"issue":"16","key":"10.1016\/j.lfs.2020.118052_bb0080","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1073\/pnas.0902280106","article-title":"G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models","volume":"106","author":"Shojaei","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.lfs.2020.118052_bb0085","first-page":"3438","article-title":"Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor","volume":"55","author":"Tachibana","year":"1995","journal-title":"Cancer Res."},{"issue":"32","key":"10.1016\/j.lfs.2020.118052_bb0090","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2020.118052_bb0095","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3389\/fimmu.2019.02088","article-title":"IL-1\u03b2 blockade attenuates thrombosis in a neutrophil extracellular trap-dependent breast cancer model","volume":"10","author":"Monteiro","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118052_bb0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4161\/mabs.29089","article-title":"Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancer","volume":"6","author":"Fauvel","year":"2014","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.lfs.2020.118052_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1293\/tox.2015-0031","article-title":"Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies","volume":"28","author":"Suzuki","year":"2015","journal-title":"J. Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118052_bb0110","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/nnm.13.86","article-title":"Nanobodies and their potential applications","volume":"8","author":"Hassanzadeh-Ghassabeh","year":"2013","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.lfs.2020.118052_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ddtec.2010.03.002","article-title":"Nanobodies\u2013from llamas to therapeutic proteins","volume":"7","author":"Kolkman","year":"2010","journal-title":"Drug Discov. Today Technol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118052_bb0120","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cell.2013.07.021","article-title":"A nanobody-based system using fluorescent proteins as scaffolds for cell-specific gene manipulation","volume":"154","author":"Tang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118052_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.biopha.2017.06.025","article-title":"Identification and in vitro characterization of novel nanobodies against human granulocyte colony-stimulating factor receptor to provide inhibition of G-CSF function","volume":"93","author":"Bakherad","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.lfs.2020.118052_bb0130","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/j.1460-2075.1991.tb07835.x","article-title":"Functional domains of the granulocyte colony-stimulating factor receptor","volume":"10","author":"Fukunaga","year":"1991","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.lfs.2020.118052_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0092-8674(90)90814-U","article-title":"Expression cloning of a receptor for murine granulocyte colony-stimulating factor","volume":"61","author":"Fukunaga","year":"1990","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.lfs.2020.118052_bb0140","doi-asserted-by":"crossref","first-page":"17445","DOI":"10.1074\/jbc.274.25.17445","article-title":"Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor. Evidence that Glu19 of G-CSF interacts with Arg288 of the receptor","volume":"274","author":"Layton","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2020.118052_bb0145","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pro.5560060611","article-title":"Characterization of the receptor binding determinants of granulocyte colony stimulating factor","volume":"6","author":"Young","year":"1997","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.lfs.2020.118052_bb0150","first-page":"256","article-title":"Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin","volume":"16","author":"Hara","year":"1988","journal-title":"Exp. Hematol."},{"issue":"23","key":"10.1016\/j.lfs.2020.118052_bb0155","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.85.23.9253","article-title":"Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin","volume":"85","author":"Dedhar","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"50","key":"10.1016\/j.lfs.2020.118052_bb0160","doi-asserted-by":"crossref","first-page":"21248","DOI":"10.1073\/pnas.1015855107","article-title":"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+ Ly6C+ granulocytes","volume":"107","author":"Kowanetz","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2020.118052_bb0165","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.0.CO;2-C","article-title":"Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression","volume":"83","author":"Mueller","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.lfs.2020.118052_bb0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrrheum.2009.178","article-title":"G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis","volume":"5","author":"Cornish","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118052_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","article-title":"Therapeutic antibodies: successes, limitations and hopes for the future","volume":"157","author":"Chames","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118052_bb0180","first-page":"1","article-title":"The therapeutic potential of nanobodies","author":"Jov\u010devska","year":"2019","journal-title":"BioDrugs"},{"issue":"22","key":"10.1016\/j.lfs.2020.118052_bb0185","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1073\/pnas.87.22.8702","article-title":"Three different mRNAs encoding human granulocyte colony-stimulating factor receptor","volume":"87","author":"Fukunaga","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2020.118052_bb0190","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","article-title":"Ligand binding assays at equilibrium: validation and interpretation","volume":"161","author":"Hulme","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118052_bb0195","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2013.08.298","article-title":"Targeting tumors with nanobodies for cancer imaging and therapy","volume":"172","author":"Oliveira","year":"2013","journal-title":"J. Control. Release"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:19:07Z","timestamp":1765228747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S0024320520308031"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118052","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118052"}}